Merck - Quarterly Results
27th Feb 2019

The company witnessed a 14.47% growth in the revenue at Rs. 2043.93 millions for the quarter ended December 2018 as compared to Rs. 1785.56 millions during the year-ago period.A slender decline of -1.87% was recorded to Rs. 134.84  millions from Rs. 137.41 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 225.20 millions from 116.38 millions in the same quarter last year.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201812 201712 % Var
Sales 2043.93 1785.56 14.47 8489.95 7114.68 19.33 8489.95 7114.68 19.33
Other Income 71.75 75.19 -4.58 243.88 240.70 1.32 243.88 240.70 1.32
PBIDT 225.20 116.38 93.50 1725.35 1010.38 70.76 1725.35 1010.38 70.76
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 225.20 286.37 -21.36 1791.00 1180.37 51.73 1791.00 1180.37 51.73
Depreciation 46.30 51.06 -9.32 211.20 191.20 10.46 211.20 191.20 10.46
PBT 178.90 235.31 -23.97 1579.80 989.17 59.71 1579.80 989.17 59.71
TAX 44.06 97.90 -54.99 562.43 378.80 48.48 562.43 378.80 48.48
Deferred Tax 19.44 -68.73 -128.28 60.15 -66.60 -190.32 60.15 -66.60 -190.32
PAT 134.84 137.41 -1.87 1017.37 610.37 66.68 1017.37 610.37 66.68
Equity 165.99 165.99 0.00 165.99 165.99 0.00 165.99 165.99 0.00
PBIDTM(%) 11.02 6.52 69.04 20.32 14.20 43.10 20.32 14.20 43.10